Immunome Inc.·4

Nov 25, 8:35 AM ET

Lechleider Robert 4

4 · Immunome Inc. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-21
Lechleider Robert
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2024-11-21$9.48/sh+15,805$149,80015,805 total
Footnotes (1)
  • [F1]The purchase price for the reported transactions was $9.478. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased.

Documents

1 file
  • 4
    form4-11252024_011125.xmlPrimary